Know Cancer

or
forgot password

Prospective Analysis of Liver Cancer Treatment and Interventions


N/A
18 Years
N/A
Open (Enrolling)
Both
Liver Cancer

Thank you

Trial Information

Prospective Analysis of Liver Cancer Treatment and Interventions


Inclusion Criteria:



- Patients diagnosed with Hepatocellular carcinoma and referred for percutaneous liver
treatment.

Exclusion Criteria:

- Severe liver disfunction

- Active uncontrolled infection

- Significant underlying medical of physical illness

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Assess efficacy of percutaneous and transarterial treatments for liver cancer.

Outcome Description:

QOL questionnaire will be collected during follow up visit.

Outcome Time Frame:

1 month

Safety Issue:

No

Principal Investigator

Kevin S Kim, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Emory University

Authority:

United States: Institutional Review Board

Study ID:

00014768

NCT ID:

NCT01539993

Start Date:

November 2008

Completion Date:

August 2016

Related Keywords:

  • Liver Cancer
  • Hepatocellular carcinoma
  • Liver metastases
  • Cholangiocarcinoma
  • Percutaneous treatments
  • RFA
  • TACE
  • DEB
  • Liver Neoplasms

Name

Location

Emory UniversityAtlanta, Georgia  30322